Publication: XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.
No Thumbnail Available
Date
2013-01-01T00:00:00Z
Authors
Authors
UYGUN, K
BILICI, A
KAYA, S
Oven, Ustaalioglu
YILDIZ, R
TEMIZ, S
Seker, MESUT
AKSU, G
CABUK, D
GUMUS, M
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Description
Keywords
Citation
UYGUN K., BILICI A., KAYA S., Oven U., YILDIZ R., TEMIZ S., Seker M., AKSU G., CABUK D., GUMUS M., -XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.-, Asian Pacific journal of cancer prevention : APJCP, cilt.14, ss.2283-8, 2013